Progression of Metastatic Pancreatic Cancer
2 विचारों
administrator
07/30/23
George Kim, MD, discusses treatment options for second-line therapy in patients with gemcitabine-refractory pancreatic cancer based on the NCCN guidelines.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली